Project Kenny
Supported by a $50,000 Glioblastoma Research Organization grant, Project Kenny pioneers the first fully implantable, rechargeable Tumor Treating Fields (TTF) device aimed at delivering 24/7 therapy without external hardware.
Supported by a $50,000 Glioblastoma Research Organization grant, Project Kenny pioneers the first fully implantable, rechargeable Tumor Treating Fields (TTF) device aimed at delivering 24/7 therapy without external hardware.